Subscribe to RSS

DOI: 10.1055/a-2719-3047
A case of tumor-related hemobilia successfully treated with radiofrequency ablation diagnosed by peroral cholangioscopy
Authors
Radiofrequency ablation (RFA) is a treatment that uses high frequency electrical current to induce coagulative necrosis of tumors. In the biliary tract, RFA has been reported as a palliative option to reduce tumor burden and maintain ductal patency, often combined with stenting; however, strong evidence supporting its efficacy remains limited [1] [2] [3]. Hemobilia, especially when tumor-related, presents significant diagnostic and therapeutic challenges and can be life-threatening. We report a case in which the bleeding source was identified via peroral cholangioscopy (POCS), and hemostasis was successfully achieved using RFA.
A 72-year-old man presented with persistent epigastric pain. Laboratory tests revealed elevated total bilirubin (4.2 mg/dL), AST (518 U/L), ALT (304 U/L), and ALP (228 U/L). Contrast-enhanced computed tomography (CT) showed a hypovascular tumor in segment 4 ([Fig. 1]) and a hyperdense area within the bile duct, suggestive of intraductal blood. Endoscopic retrograde cholangiopancreatography (ERCP) revealed a radiolucent filling defect, which was removed using a balloon catheter and identified as a hematoma ([Fig. 2] a, b). Endoscopic nasobiliary drainage was performed to relieve jaundice and inflammation. Once jaundice improved, POCS revealed an exposed tumor in the left intrahepatic bile duct ([Fig. 3]), with ongoing tumor-related bleeding observed ([Video 1]). Biopsy confirmed adenocarcinoma.






RFA was performed using a Habib EndoHPB catheter (Boston Scientific, Marlborough, Massachusetts, USA). The first session was applied at 7 W for 90 seconds, then 10 W for 90 seconds. Follow-up POCS one week later showed partial tumor ablation but mild persistent bleeding. A second RFA session at 10 W for 90 seconds, repeated twice, achieved hemostasis ([Fig. 4], [Video 1]). The patient’s condition improved without anemia progression, and chemotherapy with gemcitabine and S-1 was initiated. No tumor-related bleeding recurred during seven months of follow-up.


Endoscopy_UCTN_Code_TTT_1AR_2AF
E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy.
All papers include a high-quality video and are published with a Creative Commons
CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission
process. We grant 100% waivers to articles whose corresponding authors are based in
Group A countries and 50% waivers to those who are based in Group B countries as classified
by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.
Publication History
Article published online:
14 November 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Balducci D, Montori M, Martini F. et al. The impact of radiofrequency ablation on survival outcomes and stent patency in patients with unresectable cholangiocarcinoma: A systematic review and meta-analysis of randomized controlled trials. Cancers (Basel) 2024; 16: 1372
- 2 Inoue T, Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction. Dig Endosc 2022; 34: 345-358
- 3 Takenaka M, Lee T H. Role of radiofrequency ablation in advanced malignant hilar biliary obstruction. Clin Endosc 2023; 56: 155-163
